Cargando…

Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes

We report the case of a patient with type 1 diabetes who developed acute severe diabetic ketoacidosis following ingestion of an energy supplement containing caffeine. Some 95% of the US adult population consume caffeine, and the general perception is that there are no negative consequences for healt...

Descripción completa

Detalles Bibliográficos
Autor principal: Hamed, Ehab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346890/
https://www.ncbi.nlm.nih.gov/pubmed/30755983
http://dx.doi.org/10.12890/2018_000957
_version_ 1783389843311558656
author Hamed, Ehab
author_facet Hamed, Ehab
author_sort Hamed, Ehab
collection PubMed
description We report the case of a patient with type 1 diabetes who developed acute severe diabetic ketoacidosis following ingestion of an energy supplement containing caffeine. Some 95% of the US adult population consume caffeine, and the general perception is that there are no negative consequences for health. The upper limit of safe consumption is less than 400 mg per day. However, acute ingestion of high doses of caffeine may cause significant metabolic changes that can be fatal. Here the patient consumed a toxic dose of caffeine causing unpleasant and puzzling symptoms, vomiting and, following omission of his long-acting basal insulin, severe diabetic ketoacidosis. As the sports nutrition market continues to expand, providers and manufacturers have a responsibility to give clear and accurate dosing instructions as well as side effect profiles for their products, particularly for diabetic patients. LEARNING POINTS: The impact of caffeine on blood glucose levels has implications for people with diabetes who may be thinking of consuming supplements containing caffeine. Providers of sports supplements have a responsibility to provide an accurate description of the side effects with a clear warning for diabetic patients. Legislators should review protocols for regulating the sports and nutritional supplements industry.
format Online
Article
Text
id pubmed-6346890
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SMC Media Srl
record_format MEDLINE/PubMed
spelling pubmed-63468902019-02-12 Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes Hamed, Ehab Eur J Case Rep Intern Med Articles We report the case of a patient with type 1 diabetes who developed acute severe diabetic ketoacidosis following ingestion of an energy supplement containing caffeine. Some 95% of the US adult population consume caffeine, and the general perception is that there are no negative consequences for health. The upper limit of safe consumption is less than 400 mg per day. However, acute ingestion of high doses of caffeine may cause significant metabolic changes that can be fatal. Here the patient consumed a toxic dose of caffeine causing unpleasant and puzzling symptoms, vomiting and, following omission of his long-acting basal insulin, severe diabetic ketoacidosis. As the sports nutrition market continues to expand, providers and manufacturers have a responsibility to give clear and accurate dosing instructions as well as side effect profiles for their products, particularly for diabetic patients. LEARNING POINTS: The impact of caffeine on blood glucose levels has implications for people with diabetes who may be thinking of consuming supplements containing caffeine. Providers of sports supplements have a responsibility to provide an accurate description of the side effects with a clear warning for diabetic patients. Legislators should review protocols for regulating the sports and nutritional supplements industry. SMC Media Srl 2018-10-24 /pmc/articles/PMC6346890/ /pubmed/30755983 http://dx.doi.org/10.12890/2018_000957 Text en © EFIM 2018 This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Articles
Hamed, Ehab
Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes
title Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes
title_full Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes
title_fullStr Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes
title_full_unstemmed Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes
title_short Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes
title_sort caffeine toxicity following ingestion of an exercise supplement by a patient with type 1 diabetes
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346890/
https://www.ncbi.nlm.nih.gov/pubmed/30755983
http://dx.doi.org/10.12890/2018_000957
work_keys_str_mv AT hamedehab caffeinetoxicityfollowingingestionofanexercisesupplementbyapatientwithtype1diabetes